StockData
Zura Bio Ltd logo

Zura Bio Ltd (ZURA) stock

ZURANasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 27, 2026Score 5/30
$0.97−0.07 (-6.75%)

Close on Nov 18, 2026Market cap $92.96MP/E –Yield –

Zura Bio ebitda

EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.

Zura Bio's ebitda for the twelve months ending Sep 30, 2026 was -$101.95M. For fiscal 2025 it was -$75.20M.

Annual ebitda

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$75.20M–
FY2024Dec 31, 2024-$55.18M–

Quarterly ebitda

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026-$28.77M–
Q2 FY2026Jun 30, 2026-$29.34M–
Q1 FY2026Mar 31, 2026-$25.48M–
Q4 FY2025Dec 31, 2025-$18.36M–
Q3 FY2025Sep 30, 2025-$19.52M–
Q2 FY2025Jun 30, 2025-$18.07M–
Q1 FY2025Mar 31, 2025-$19.25M–
Q4 FY2024Dec 31, 2024-$15.73M–
Q3 FY2024Sep 30, 2024-$19.32M–

More Zura Bio figures

See a number that looks wrong?